Clinical Stage Evaluation at Diagnosis of Prostate Cancer at Urology-Andrology Clinic Cnhu-Hkm Cotonou
- 1 Urology-Andrology, Faculty of Medecine, CNHU-HKM, Cotonou, Benin
- 2 Urology-Andrology, Faculty of Medecine, CNHU-HKM, Cotonou, Benin
- 3 Urology-Andrology, Faculty of Medecine, CNHU-HKM, Cotonou, Benin
- 4 Urology-Andrology, Faculty of Medecine, CNHU-HKM, Cotonou, Benin
- 5 Urology-Andrology, Faculty of Medicine, CHD-OP, Porto-Novo, Benin
- 6 Urology-Andrology, Faculty of Medecine, CNHU-HKM, Cotonou, Benin
Abstract
Aims: To evaluate the clinical stage at diagnosis of prostate cancer. Materials and Methods: This study was retrospective and descriptive from January 2008 to June 2013. Patients who were diagnosed with prostate cancer wereinvolved and confirmed by clinical examination anatomopathological screening. They also realized a total serum PSA, a bladder-prostatic and abdominal ultrasound. Results: Average age was seventy years, ranging from fifty years to seventy years. The general status of our patients was satisfactory in 78% of cases. Main symptoms were dysuria and frequencyin 96% and 86%, respectively. Family past history of prostate cancer were found in 24% of cases. Twenty-three patients (43%) had a total serum PSA ≥ 100 ng/ml. Adenocarcinoma was the main histological type. Grades 1 and 4 were the most frequent. Thirty-three patients (66%) had a Gleasonscore betwen [2]-[6]. Forty-four patients (88%) had locally advanced and metastatic desease. The D’Amico score was identified in six patients but 3 and 2 patients were low risk and intermediate riskrespectively. Finally, 1 patient was high risk. Conclusion: Prostate cancer remains elderly man cancer. It was discovered in locally advanced and metastatic desease in this series. This diagnosis was late in the majority of cases.
- Amegbor, K., Yao Seddoh, T., Tengue, K., Napo-Koura, G., Songne-Gnamkoulamba, B. and James, K. (2009) Epidemiology and Histopronostic of Prostatic Cancer in Togo: About 202 Cases Diagnosed at the Laboratory of Pathology of the Tokoin Teaching Hospital of Lome. Progres en Urologie, 19, 112-115.http://dx.doi.org/10.1016/j.purol.2008.10.008
- Soulie, M. (2003) Cancer Epidemiology. Progres en Urologie, 13, 1261.
- Aus, G., Hugosson, J. and Norlen, L. (1995) Long-Term Survival and Mortality in Prostate Cancer Treated with Non Curative Intent. Journal of Urology, 154, 460-465. http://dx.doi.org/10.1016/S0022-5347(01)67074-5
- McNeal, J. (1968) Rjegional Morphology and Pathology of the Prostate. American Journal of Pathology, 49, 347-357.
- Soulie, M., Barre, C., Beuzeboc, P., Chautard, D., Cornud, F., Eschwege, P., Fontaine, E., Molinie, V., Moreau, J.L., Peneau, M., Ravery, V., Rebillard, X., Richaud, P., Ruffion, A., Salomon, L., Staerman, F. and Villers, A., Comite de Cancerologie de l’Association Française d’Urologie (2004) Prostatic Cancer. Progres en Urologie, 14, 913-955.
- Niang, L., Ndoye, M., Ouattara, A., Jalloh, M., Labou, I., Thia, I., Kouka, S.C., Diaw, J.J. and Gueye, S.M. (2013) Management of Prostate Cancer in Senegal: What Is Being Done? Progres en Urologie, 23, 36-41.http://dx.doi.org/10.1016/j.purol.2012.09.002
- Catalona, W., Richie, J., Ahman, F., Hudson, M., Scardino, P., Flanigan, R., Dekernion, J.B., Ratliff, T.L., Kavoussi, L.R. and Dalkin, B.L. (1994) Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen. Journal of Urology, 151, 1283-1290.
- Stamey, T., Johnstone, I., McNeal, J., Ay, L.U. and Yemoto, C.M. (2002) Preoperative Serum Prostate Specific Antigen Levels. Journal of Urology, 167, 103-111. http://dx.doi.org/10.1016/S0022-5347(05)65392-X
- Villers, A., Rébillard, X., Soulié, M., Davin, J., Coloby, P., Moreau, J., Mejean, A., Irani, J., Coulange, C. and Mangin, P., French Association of Urology (2003) Prostate Cancer Screening. Progres en Urologie, 13, 209-214.
- Boccon-Gibod, L. Prostate Cancer: Diagnostic and Therapeutic Strategies. AKOS Encyclopedia of Medicine Practice, 5-0692.
- Descotes, J., Hubert, J., Rouvière, O. and Artignan, X. (2003) Urology Imaging: Contribution of Imaging in Prostatic Cancer. Progrès en Urologie, 13, 843-884.
- Sandhu, D., Mayor, P., Sambrook, P. and George, N. (1992) Outcome and Prognostic Factors in Patients with Advanced Prostate Cancer and Obstructive Uropathy. British Journal of Urology, 70, 412-416.http://dx.doi.org/10.1111/j.1464-410X.1992.tb15799.x